Your browser doesn't support javascript.
loading
Os LncRNAs Estão Envolvidos no Processo de Aterosclerose em Diversos Níveis / LncRNAs are Involved in the Process of Atherosclerosis at Diverse Levels
Liang, Shiyi; Xv, Weicheng; Li, Chijian; Huang, Yuxiang; Qian, Ge; Yan, Yuxiang; Zou, Hequn; Li, Yongqiang.
  • Liang, Shiyi; The Third Affiliated Hospital of Southern Medical University. Department of Nephrology. Guangzhou. CN
  • Xv, Weicheng; The Third Affiliated Hospital of Southern Medical University. Department of Nephrology. Guangzhou. CN
  • Li, Chijian; The Third Affiliated Hospital of Southern Medical University. Department of Nephrology. Guangzhou. CN
  • Huang, Yuxiang; The Third Affiliated Hospital of Southern Medical University. Department of Nephrology. Guangzhou. CN
  • Qian, Ge; The Third Affiliated Hospital of Southern Medical University. Department of Nephrology. Guangzhou. CN
  • Yan, Yuxiang; Capital Medical University. Department of Epidemiology and Biostatistics. Beijing. CN
  • Zou, Hequn; South China Hospital of Shenzhen University. Department of Nephrology. Beijing. CN
  • Li, Yongqiang; The Third Affiliated Hospital of Southern Medical University. General Practice Department. Guangzhou. CN
Arq. bras. cardiol ; 118(6): 1134-1140, Maio 2022. tab, graf
Article Dans Portugais | LILACS-Express | LILACS | ID: biblio-1383694
RESUMO
Resumo A aterosclerose é a causa mais comum de doença cardiovascular em todo o mundo, ela está associada a uma alta incidência de eventos clínicos. O acúmulo de evidências elucidou que os RNAs longos não codificantes (LncRNAs) são uma nova classe de transcritos com papéis críticos nos processos fisiopatológicos da aterosclerose. Nesta revisão, resumimos o progresso recente dos LncRNAs no desenvolvimento da aterosclerose. Descrevemos principalmente os diversos mecanismos regulatórios dos LncRNAs nos níveis transcricionais e pós-transcricionais. Este estudo pode fornecer informações úteis sobre os LncRNAs como alvos terapêuticos ou biomarcadores para o tratamento da aterosclerose.
ABSTRACT
Abstract Atherosclerosis is the most common cause of cardiovascular disease globally, associated with a high incidence of clinical events. Accumulating evidence has elucidated that long non-coding RNAs (lncRNAs) as a novel class of transcripts with critical roles in the pathophysiological processes of atherosclerosis. In this review, we summarize the recent progress of lncRNAs in the development of atherosclerosis. We mainly describe the diverse regulatory mechanisms of lncRNAs at the transcriptional and post-transcriptional levels. This study may provide helpful insights about lncRNAs as therapeutic targets or biomarkers for atherosclerosis treatment.


Texte intégral: Disponible Indice: LILAS (Amériques) langue: Portugais Texte intégral: Arq. bras. cardiol Thème du journal: Cardiologie Année: 2022 Type: Article / descriptif de projet Pays d'affiliation: Chine Institution/Pays d'affiliation: Capital Medical University/CN / South China Hospital of Shenzhen University/CN / The Third Affiliated Hospital of Southern Medical University/CN

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) langue: Portugais Texte intégral: Arq. bras. cardiol Thème du journal: Cardiologie Année: 2022 Type: Article / descriptif de projet Pays d'affiliation: Chine Institution/Pays d'affiliation: Capital Medical University/CN / South China Hospital of Shenzhen University/CN / The Third Affiliated Hospital of Southern Medical University/CN